📢 Publish Your Research for Free - Full APC Waiver, No Hidden Charges. Submit Your Article Today! Submit Now →

Editor Profile

editor profile image is not found.

Dr. Abdulhamid Shafei Fatani, Ph.D.

Researcher

Present

University College London

London

United Kingdom

editor profile QR Code is not found.

Name: Abdulhamid Shafei Fatani

E-mail: dr.fatani1@hotmail.com

Address: National Hospital for Neurology & Neurosurgery – (UCLH), London, UK.

Education:

MPhil & PhD in Pharmacology, Nanomedicine, Gene & Cell Therapy
University College London – Institute of Neurology
Grade: Excellent | Years: 2021 – 2024 (Full-time)

Postgraduate Diploma in Cell and Gene Therapy (Pediatrics)
University College London – Institute of Child Health
Grade: Merit | Years: 2020 – 2021

MBBS – Bachelor of Medicine and Bachelor of Surgery
King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard, Riyadh, Saudi Arabia
GPA: 3.9/5 (Very Good) | Years: 2016 – 2020

Bachelor in Laboratory Medicine
Umm Al-Qura University, Faculty of Applied Medical Sciences, Makkah, Saudi Arabia
GPA: 4.25/5 (Very Good, Second Honors) | Years: 2011 – 2016

  • Neurosurgery
  • Pharmacology
  • Gene & Cell Therapy
  • Role of inorganic polyphosphate in reactive oxygen species in primary neurons and astrocytes (For submission).
  • Gene therapy for chronic pain syndrome (For submission).
  • Fatani A.S., Schätzlein A.G., Uchegbu I.F., Targeting intracranial tumours with a combination of RNA and chemotherapy, Pharmaceutics, 16(6): 829, June 2024. doi: 10.3390/pharmaceutics16060829. PMID: 38931949; PMCID: PMC11207522.
  • Fatani A.S., Petkova A., Schatzlein A.G., Uchegbu I.F., Dose-dependent delivery of genes to the cerebral cortex via the nasal route, International Journal of Pharmaceutics, 644: 123343, September 2023. doi: 10.1016/j.ijpharm.2023.123343. PMID: 37633538.
  • Fatani A., Al-Rouqi K., Al Towairky J., Ahmed A.E., Al-Jahdali S., Ali Y., Al-Shimemeri A., Al-Harbi A., Baharoon S., Khan M., Al-Jahdali H., Effect of age and gender on prevalence of excessive daytime sleepiness in Saudi population, Journal of Epidemiology and Global Health, 5(4 Suppl 1): S59–66, December 2015. doi: 10.1016/j.jegh.2015.05.005. PMID: 26099548.
  • Abumaree M.H., Al Jumah M.A., Kalionis B., Jawdat D., Al Khaldi A., Abomaray F.M., Fatani A.S., Chamley L.W., Knawy B.A., Human placental mesenchymal stem cells (pMSCs) act as immune suppressive cells by shifting macrophage differentiation from M1 to M2, Stem Cell Reviews, 9(5): 620–641, October 2013. doi: 10.1007/s12015-013-9455-2. PMID: 23812784.
  • Ahmed A.E., Fatani A., Al-Harbi A., Al-Shimemeri A., Ali Y.Z., Baharoon S., Al-Jahdali H., Validation of the Arabic version of the Epworth Sleepiness Scale, Journal of Epidemiology and Global Health, 4(4): 297–302, December 2014. doi: 10.1016/j.jegh.2014.04.004. PMID: 25455647.
  • Elhawary N.A., Bogari N., Jiffri E.H., Rashad M., Fatani A., Tayeb M., TAP1-637G and PSMB9-60H variants influence vitiligo risk in Saudi population, Disease Markers, 2014: 260732, December 2014. doi: 10.1155/2014/260732. PMID: 25548428; PMCID: PMC4273470.
  • Ahmed A.E., Al-Jahdali H., Fatani A., Al-Rouqi K., Al-Jahdali F., Al-Harbi A., Baharoon S., Ali Y.Z., Khan M., Rumayyan A., Effects of age and gender on prevalence of insomnia in Saudi population, Ethnicity & Health, 22(3): 285–294, June 2017. doi: 10.1080/13557858.2016.1244624. PMID: 27846729.
  • Sherbini N.A., Ahmad A., Fatani A., Al-Otaibi K., Al-Jahdali S., Ali Y., Al-Harbi A., Khan M., Baharoon S., Al-Jahdali H., Prevalence and risk factors of restless legs syndrome among Saudi adults, American Journal of Respiratory and Critical Care Medicine, 193: A4226, 2016.
    No content available to display!!!